Antiviral effect of the mammalian translation initiation factor 2α kinase GCN2 against RNA viruses

• DOI: 10.1038/sj.emboj.7601073
• Publication Date: 2006-04-06T22:17:23Z
• Authors: Juan J Berlanga; Iván Ventoso; Heather P Harding; Jing Deng; David Ron; Nahum Sonenberg; Luis Carrasco; César de Haro
• Keywords: 0303 health sciences; Alphavirus Infections; Brain; Genome, Viral; Protein Serine-Threonine Kinases; Virus Replication; Biochemistry; Vesicular stomatitis Indiana virus; Cell Line; 3. Good health; Enzyme Activation; Mice; 03 medical and health sciences; Protein Biosynthesis; Mutation; Animals; Humans; RNA, Viral; Sindbis Virus; Protein Kinases

In mammals, four different protein kinases, heme-regulated inhibitor, double-stranded RNA-dependent protein kinase (PKR), general control non-derepressible-2 (GCN2) and PKR-like endoplasmic reticulum kinase, regulate protein synthesis in response to environmental stresses by phosphorylating the alpha-subunit of the initiation factor 2 (eIF2alpha). We now report that mammalian GCN2 is specifically activated in vitro upon binding of two nonadjacent regions of the Sindbis virus (SV) genomic RNA to its histidyl-tRNA synthetase-related domain. Moreover, endogenous GCN2 is activated in cells upon SV infection. Strikingly, fibroblasts derived from GCN2-/- mice possess an increased permissiveness to SV or vesicular stomatitis virus infection. We further show that mice lacking GCN2 are extremely susceptible to intranasal SV infection, demonstrating high virus titers in the brain compared to similarly infected control animals. The overexpression of wild-type GCN2, but not the catalytically inactive GCN2-K618R variant, in NIH 3T3 cells impaired the replication of a number of RNA viruses. We determined that GCN2 inhibits SV replication by blocking early viral translation of genomic SV RNA. These findings point to a hitherto unrecognized role of GCN2 as an early mediator in the cellular response to RNA viruses.